TickerWorth Open the interactive view →

The Bank of Nova Scotia (BNS) — Valuation Snapshot

Updated Nov 10, 2026 · bank / insurer · bank model (justified price-to-book) · descriptive, not a DCF, not advice

This is a bank / insurer / financial. A free-cash-flow DCF is structurally the wrong lens here (their debt and float are raw material, not financing), so we don't publish one. Instead we value it with a bank model — justified price-to-book, (ROE − g) ÷ (cost of equity − g), on a return on equity of 11.5% and a cost of equity of 10.5% — at about $58.16 a share ($51.72–$66.45 for a cost of equity one point either way), against a price of $93.34. A dividend-discount cross-check gives about $41.39. Every input is listed with its source; it is a model estimate, not a price target.
Price
$93.34
Market cap
$113,576,714,240
52-week high
$96.85
52-week low
$65.99
Currency
USD
Exchange
NYSE

The Bank of Nova Scotia (BNS) is a bank, insurer or other financial, and a free-cash-flow discounted-cash-flow (DCF) model is structurally the wrong lens for it: for these businesses debt and float are raw material, not financing. So we value it the way a bank is valued — on the return it earns on its book equity. Our bank model (justified price-to-book) puts it at about $58.16 a share, between $51.72 and $66.45 for a cost of equity one point either side of 10.5%, against $93.34 today. Every input is listed with its source. It is a model estimate, not a price target, and not investment advice.

On the numbers we do have, BNS trades at a recent price of $93.34, a market capitalisation of about $113,576,714,240, sitting 89% of the way up its 52-week range ($65.99–$96.85), on the NYSE.

The standard alternative to a DCF is relative valuation — comparing BNS's trading multiples against a sector benchmark. Here that gives P/E of 16.6× (richer than the peer median of 14.0×); Fwd P/E of 13.8× (in line with the peer median of 13.4×); P/B of 1.8× (cheaper than the peer median of 2.6×); P/S of 3.2× (cheaper than the peer median of 4.8×); Dividend yield of 3.5% (cheaper than the peer median of 1.9%). A cheaper multiple than peers can flag a discount or a market that expects weaker growth; it is a comparison, not a recommendation.

The asset, or book-value, lens is the classic tool for asset-heavy businesses and financials. BNS shows a price-to-book (P/B) of 1.79 and book value of $52.09 per share. Price-to-book compares the market price to the accounting net-asset value per share; below 1.0 can mean a discount to net assets or that the market is pricing in trouble — descriptive either way, never a buy signal on its own.

Finally, a price-based read — explicitly not a valuation. BNS is in an up-trend (price above both its 50- and 200-day averages), trading -3.6% from its 52-week high. Over the past year the stock is +36.4%. Moving-average trend and 52-week position describe where the stock has traded; they say nothing about what it is worth.

To be exact about what this page is not: we are not saying the numbers for BNS are unavailable. They are, and they are above. We are saying a discounted-cash-flow model is the wrong instrument for this kind of business, and publishing one anyway — because the inputs happen to exist — would be a precise answer to the wrong question. Refusing is the more useful answer, and it is the same rule we apply to every name in this category.

Relative valuation — BNS vs peers

MultipleBNSPeer median
P/E16.6×14.0×richer than
Fwd P/E13.8×13.4×in line with
P/B1.8×2.6×cheaper than
P/S3.2×4.8×cheaper than
Dividend yield3.5%1.9%cheaper than

Sector benchmark (bellwethers, not direct competitors).

Asset / book-value view

Price / book (P/B)
1.79
Book value / share
$52.09

Price-to-book compares the market price to the accounting net-asset value per share. Most useful for asset-heavy businesses, banks and insurers.

Price-based snapshot

50-day avg
$92.39
200-day avg
$82.87
From 52-wk high
-3.6%
1-year momentum
+36.4%

Price-based, not a valuation. Moving-average trend and 52-week position describe where the stock has traded — they say nothing about fair value.

Explore more

Most undervalued stocks (per our valuation) · All valued stocks · Interactive BNS view

A bank-model estimate beside an available-data snapshot — NOT a DCF, NOT a price target, and NOT investment advice. TickerWorth is an educational tool, not a licensed investment adviser. Figures are estimates derived from public market data and can be wrong, stale or incomplete.